Oxypro 40mg modified-release tablets
BNF presentation 0407020ADBSAFAH within chapter Central Nervous System. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Chapter
Presentation code
0407020ADBSAFAH
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
6,255
NHS spend (£)
£117,722.73
Recent activity
March 2025
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| March 2025 | 1,058 |
| February 2025 | 7 |
| December 2024 | 243 |
| November 2024 | 1,147 |
| October 2024 | 1,232 |
| September 2024 | 4 |
| August 2024 | 54 |
| July 2024 | 1,134 |
| May 2024 | 217 |
| July 2021 | 196 |
| June 2021 | 123 |
| December 2020 | 388 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
| Unknown pharmacy | 113 | No data available |
| Unknown pharmacy | 63 | No data available |
| Unknown pharmacy | 58 | No data available |
| Unknown pharmacy | 51 | No data available |
|
Holderness Health
ODS B81025
|
43 | 02Y - HUMBER AND NORTH YORKSHIRE ICB |
| Unknown pharmacy | 41 | No data available |
| Unknown pharmacy | 39 | No data available |
| Unknown pharmacy | 37 | No data available |
| Unknown pharmacy | 32 | No data available |
| Unknown pharmacy | 32 | No data available |